UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Current adjuvants and new perspectives in vaccine formulation

Expert review of vaccines, 2011-07, Vol.10 (7), p.1053-1061

2011

Volltextzugriff (PDF)

Vaccination with Autologous Tumor-derived Heat-Shock Protein Gp96 after Liver Resection for Metastatic Colorectal Cancer

Clinical cancer research, 2003-08, Vol.9 (9), p.3235-3245

2003

Volltextzugriff (PDF)

Strong immunogenicity of heterologous prime-boost immunizations with the experimental vaccine GRAd-COV2 and BNT162b2 or ChAdOx1-nCOV19

npj vaccines, 2021-11, Vol.6 (1), p.131-131, Article 131

2021

Volltextzugriff (PDF)

Large Randomized Study of Thymosin α 1, Interferon Alfa, or Both in Combination With Dacarbazine in Patients With Metastatic Melanoma

Journal of clinical oncology, 2010-04, Vol.28 (10), p.1780-1787

2010

Volltextzugriff (PDF)

Historical review of thymosin α 1 in infectious diseases

Expert opinion on biological therapy, 2015-06, Vol.15 (sup1), p.117-127

2015

Volltextzugriff (PDF)

Primary Analysis and 4-Year Follow-Up of the Phase III NIBIT-M2 Trial in Melanoma Patients With Brain Metastases

Clinical cancer research, 2021-09, Vol.27 (17), p.4737-4745

2021

Volltextzugriff (PDF)

Corrigendum to “Nivolumab plus ipilimumab in melanoma patients with asymptomatic brain metastases: 7-year outcomes and quality of life from the multicenter phase III NIBIT-M2 trial” [Eur J Cancer 199 (2024) 113531]

European journal of cancer (1990), 2024-05, Vol.202, p.113981-113981, Article 113981

2024

Volltextzugriff (PDF)

Nivolumab plus ipilimumab in melanoma patients with asymptomatic brain metastases: 7-year outcomes and quality of life from the multicenter phase III NIBIT-M2 trial

European journal of cancer (1990), 2024-03, Vol.199, p.113531-113531, Article 113531

2024

Volltextzugriff (PDF)

Thymosin alpha 1 continues to show promise as an enhancer for vaccine response

Annals of the New York Academy of Sciences, 2012-10, Vol.1270 (1), p.21-27

2012

Volltextzugriff (PDF)

Thymosin α1 continues to show promise as an enhancer for vaccine response

Annals of the New York Academy of Sciences, 2012-10, Vol.1270 (1), p.21-27

2012

Volltextzugriff (PDF)

GRAd-COV2, a gorilla adenovirus-based candidate vaccine against COVID-19, is safe and immunogenic in younger and older adults

Science translational medicine, 2022-01, Vol.14 (627), p.eabj1996

2022

Volltextzugriff (PDF)

784 – Velusetrag Improves Gastoparesis Both in Symptoms and Gastric Emptying in Patients with Diabetic Or Idiopathic Gastroparesis in a 12-Week Global Phase 2B Study

Gastroenterology (New York, N.Y. 1943), 2019-05, Vol.156 (6), p.S-164-S-164

2019

Volltextzugriff (PDF)

Long-term follow up of metastatic melanoma patients treated with Thymosin alpha-1: investigating immune checkpoints synergy

Expert opinion on biological therapy, 2018-05, Vol.18 (sup1), p.77-83

2018

Volltextzugriff (PDF)

The Italian Network for Tumor Biotherapy (NIBIT): getting together to push the field forward

Journal of translational medicine, 2008-02, Vol.6 (1), p.8-8, Article 8

2008

Volltextzugriff (PDF)

Thymosin [alpha]1 continues to show promise as an enhancer for vaccine response

Annals of the New York Academy of Sciences, 2012-10, Vol.1270 (1), p.21

2012

Volltextzugriff (PDF)

Thymosin beta-4 and venous ulcers: clinical remarks on a European prospective, randomized study on safety, tolerability, and enhancement on healing

Annals of the New York Academy of Sciences, 2007-09, Vol.1112 (1), p.407-412

2007

Volltextzugriff (PDF)

A vision of immuno-oncology: the Siena think tank of the Italian network for tumor biotherapy (NIBIT) foundation

Journal of experimental & clinical cancer research, 2021-07, Vol.40 (1), p.240-240, Article 240

2021

Volltextzugriff (PDF)

Historical review on thymosin α1 in oncology: preclinical and clinical experiences

Expert opinion on biological therapy, 2015, Vol.15 (sup1), p.31-39

2015

Volltextzugriff (PDF)

Propionyl-L-Carnitine is Efficacious in Ulcerative Colitis Through its Action on the Immune Function and Microvasculature

Clinical and translational gastroenterology, 2014-03, Vol.5 (3), p.e55-e55

2014

Volltextzugriff (PDF)

Human Tumor-Derived Heat Shock Protein 96 Mediates In Vitro Activation and In Vivo Expansion of Melanoma- and Colon Carcinoma-Specific T Cells

The Journal of immunology (1950), 2003-10, Vol.171 (7), p.3467-3474

2003

Volltextzugriff (PDF)

Studies of Therapy with Thymosin alpha 1 in Combination with Pegylated Interferon alpha 2a and Ribavirin in Nonresponder Patients with Chronic Hepatitis C

Annals of the New York Academy of Sciences, 2007-09, Vol.1112 (1), p.368-374

2007

Volltextzugriff (PDF)

Thymosin β-4 and Venous Ulcers

Annals of the New York Academy of Sciences, 2007-09, Vol.1112 (1), p.407-412

2007

Volltextzugriff (PDF)

Studies of Therapy with Thymosin α1 in Combination with Pegylated Interferon α2a and Ribavirin in Nonresponder Patients with Chronic Hepatitis C

Annals of the New York Academy of Sciences, 2007-09, Vol.1112 (1), p.368-374

2007

Volltextzugriff (PDF)

1 – 25 von 117

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(104)
Mit Volltextzugriff
(98)

Publikationsform

Artikel
(117)

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Current adjuvants and new perspectives in vaccine formulation

Vaccination with Autologous Tumor-derived Heat-Shock Protein Gp96 after Liver Resection for Metastatic Colorectal Cancer

Strong immunogenicity of heterologous prime-boost immunizations with the experimental vaccine GRAd-COV2 and BNT162b2 or ChAdOx1-nCOV19

Large Randomized Study of Thymosin α 1, Interferon Alfa, or Both in Combination With Dacarbazine in Patients With Metastatic Melanoma

Historical review of thymosin α 1 in infectious diseases

Primary Analysis and 4-Year Follow-Up of the Phase III NIBIT-M2 Trial in Melanoma Patients With Brain Metastases

Corrigendum to “Nivolumab plus ipilimumab in melanoma patients with asymptomatic brain metastases: 7-year outcomes and quality of life from the multicenter phase III NIBIT-M2 trial” [Eur J Cancer 199 (2024) 113531]

Nivolumab plus ipilimumab in melanoma patients with asymptomatic brain metastases: 7-year outcomes and quality of life from the multicenter phase III NIBIT-M2 trial

Thymosin alpha 1 continues to show promise as an enhancer for vaccine response

Thymosin α1 continues to show promise as an enhancer for vaccine response

GRAd-COV2, a gorilla adenovirus-based candidate vaccine against COVID-19, is safe and immunogenic in younger and older adults

784 – Velusetrag Improves Gastoparesis Both in Symptoms and Gastric Emptying in Patients with Diabetic Or Idiopathic Gastroparesis in a 12-Week Global Phase 2B Study

Long-term follow up of metastatic melanoma patients treated with Thymosin alpha-1: investigating immune checkpoints synergy

The Italian Network for Tumor Biotherapy (NIBIT): getting together to push the field forward

Vaccination of Metastatic Melanoma Patients With Autologous Tumor-Derived Heat Shock Protein gp96-Peptide Complexes: Clinical and Immunologic Findings

Thymosin [alpha]1 continues to show promise as an enhancer for vaccine response

Thymosin beta-4 and venous ulcers: clinical remarks on a European prospective, randomized study on safety, tolerability, and enhancement on healing

A vision of immuno-oncology: the Siena think tank of the Italian network for tumor biotherapy (NIBIT) foundation

Historical review on thymosin α1 in oncology: preclinical and clinical experiences

Propionyl-L-Carnitine is Efficacious in Ulcerative Colitis Through its Action on the Immune Function and Microvasculature

Human Tumor-Derived Heat Shock Protein 96 Mediates In Vitro Activation and In Vivo Expansion of Melanoma- and Colon Carcinoma-Specific T Cells

Safety and immune response kinetics of GRAd-COV2 vaccine: phase 1 clinical trial results

Studies of Therapy with Thymosin alpha 1 in Combination with Pegylated Interferon alpha 2a and Ribavirin in Nonresponder Patients with Chronic Hepatitis C

Thymosin β-4 and Venous Ulcers

Studies of Therapy with Thymosin α1 in Combination with Pegylated Interferon α2a and Ribavirin in Nonresponder Patients with Chronic Hepatitis C

Suchergebnisse filtern